» Articles » PMID: 36618211

Analysis of Daily COVID-19 Death Bulletin Data During the First Two Waves of the COVID-19 Pandemic in Thiruvananthapuram District, Kerala, India

Overview
Specialty Public Health
Date 2023 Jan 9
PMID 36618211
Authors
Affiliations
Soon will be listed here.
Abstract

Context: Coronavirus disease 2019 (COVID-19) mortality trends can help discern the pattern of outbreak evolution and systemic responses.

Aim: This study aimed to explore patterns of COVID-19 deaths in Thiruvananthapuram district from 31 March 2020 to 31 December 2021.

Setting And Design: Secondary data analysis of COVID-19 deaths in Thiruvananthapuram district was performed.

Materials And Methods: Mortality data were obtained from the district COVID-19 control room, and deaths in the first and second waves of COVID-19 were compared.

Statistical Analysis: We summarised data as proportions and medians with the inter-quartile range (IQR) and performed Chi-square tests to make comparisons wherever applicable.

Results: As on 31 December 2021, 4587 COVID-19 deaths were reported in Thiruvananthapuram district, with a case fatality rate of 0.91%. We observed high mortality among older persons (66.7%) and men (56.6%). The leading cause of death was bronchopneumonia (60.6%). The majority (88.5%) had co-morbidities, commonly diabetes mellitus (54.9%). The median interval from diagnosis to hospitalisation was 4 days (IQR 2-7), and that from hospitalisation to death was 2 days (IQR 0-6). The deaths reported during the second wave were four times higher than those of the first wave with a higher proportion of deaths in the absence of co-morbidities (p < 0.001). The majority of the deceased were unvaccinated. Ecological analysis with vaccine coverage data indicated 5.4 times higher mortality among unvaccinated than those who received two vaccine doses.

Conclusions: The presence of co-morbidities, an unvaccinated status, and delay in hospitalisation were important reasons for COVID-19 deaths. Primary level health providers can potentially help sustaining vaccination, expeditious referral, and monitoring of COVID-19 patients.

References
1.
Sarma P, Sadanandan R, Thulaseedharan J, Soman B, Srinivasan K, Varma R . Prevalence of risk factors of non-communicable diseases in Kerala, India: results of a cross-sectional study. BMJ Open. 2019; 9(11):e027880. PMC: 6858196. DOI: 10.1136/bmjopen-2018-027880. View

2.
Viveiros A, Rasmuson J, Vu J, Mulvagh S, Yip C, Norris C . Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Am J Physiol Heart Circ Physiol. 2020; 320(1):H296-H304. PMC: 8083171. DOI: 10.1152/ajpheart.00755.2020. View

3.
Rothman K . The rise and fall of epidemiology, 1950--2000 A.D. N Engl J Med. 1981; 304(10):600-2. DOI: 10.1056/NEJM198103053041010. View

4.
Mathews M, Spencer S, Hedden L, Marshall E, Lukewich J, Meredith L . Development of a primary care pandemic plan informed by in-depth policy analysis and interviews with family physicians across Canada during COVID-19: a qualitative case study protocol. BMJ Open. 2021; 11(7):e048209. PMC: 8300554. DOI: 10.1136/bmjopen-2020-048209. View

5.
Contou D, Cally R, Sarfati F, Desaint P, Fraisse M, Plantefeve G . Causes and timing of death in critically ill COVID-19 patients. Crit Care. 2021; 25(1):79. PMC: 7901794. DOI: 10.1186/s13054-021-03492-x. View